LifeMD (LFMD) Competitors $10.64 +0.06 (+0.57%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. TDOC, GRAL, AHCO, AGL, AVAH, VRDN, PNTG, CDNA, FLGT, and EHABShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Teladoc Health (TDOC), Grail (GRAL), AdaptHealth (AHCO), agilon health (AGL), Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), The Pennant Group (PNTG), CareDx (CDNA), Fulgent Genetics (FLGT), and Enhabit (EHAB). These companies are all part of the "healthcare" industry. LifeMD vs. Teladoc Health Grail AdaptHealth agilon health Aveanna Healthcare Viridian Therapeutics The Pennant Group CareDx Fulgent Genetics Enhabit LifeMD (NASDAQ:LFMD) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations. Do insiders & institutionals believe in LFMD or TDOC? 35.5% of LifeMD shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 16.0% of LifeMD shares are owned by company insiders. Comparatively, 0.6% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, LFMD or TDOC? LifeMD has a beta of 2.22, suggesting that its stock price is 122% more volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Is LFMD or TDOC more profitable? LifeMD has a net margin of -12.06% compared to Teladoc Health's net margin of -37.91%. LifeMD's return on equity of 0.00% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets LifeMD-12.06% N/A -36.34% Teladoc Health -37.91%-10.06%-4.86% Does the MarketBeat Community favor LFMD or TDOC? Teladoc Health received 645 more outperform votes than LifeMD when rated by MarketBeat users. However, 76.92% of users gave LifeMD an outperform vote while only 62.61% of users gave Teladoc Health an outperform vote. CompanyUnderperformOutperformLifeMDOutperform Votes4076.92% Underperform Votes1223.08% Teladoc HealthOutperform Votes68562.61% Underperform Votes40937.39% Which has better valuation & earnings, LFMD or TDOC? LifeMD has higher earnings, but lower revenue than Teladoc Health. LifeMD is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$234.01M2.07-$20.60M-$0.34-31.29Teladoc Health$2.55B0.50-$220.37M-$5.92-1.24 Do analysts recommend LFMD or TDOC? LifeMD currently has a consensus target price of $11.00, suggesting a potential upside of 3.38%. Teladoc Health has a consensus target price of $9.71, suggesting a potential upside of 32.45%. Given Teladoc Health's higher probable upside, analysts plainly believe Teladoc Health is more favorable than LifeMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.00Teladoc Health 0 Sell rating(s) 12 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.37 Does the media prefer LFMD or TDOC? In the previous week, Teladoc Health had 8 more articles in the media than LifeMD. MarketBeat recorded 10 mentions for Teladoc Health and 2 mentions for LifeMD. Teladoc Health's average media sentiment score of 1.24 beat LifeMD's score of 0.39 indicating that Teladoc Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLifeMD beats Teladoc Health on 10 of the 19 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$483.57M$1.87B$5.43B$8.47BDividend YieldN/AN/A5.22%4.11%P/E Ratio-16.6331.5126.8320.05Price / Sales2.071.63394.48119.51Price / CashN/A36.0138.2534.62Price / Book70.9316.616.874.61Net Income-$20.60M-$52.07M$3.22B$248.10M7 Day Performance24.88%3.33%5.65%2.88%1 Month Performance95.95%52.55%13.54%15.41%1 Year Performance34.68%66.15%18.16%7.68% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD1.1243 of 5 stars$10.64+0.6%$11.00+3.4%+34.7%$483.57M$234.01M-16.63230Gap UpHigh Trading VolumeTDOCTeladoc Health3.7186 of 5 stars$7.36+3.4%$9.71+32.0%-40.4%$1.29B$2.55B-1.275,100Analyst RevisionGap UpGRALGrail0.793 of 5 stars$35.99+2.2%$26.00-27.8%N/A$1.27B$125.60M0.001,360Positive NewsAHCOAdaptHealth2.5076 of 5 stars$9.11+6.3%$13.40+47.1%-6.5%$1.23B$3.25B-5.5210,900Gap UpAGLagilon health1.8912 of 5 stars$2.97+2.6%$4.89+65.0%-53.8%$1.23B$5.99B-3.15650AVAHAveanna Healthcare0.731 of 5 stars$5.78+7.0%$5.13-11.3%+97.6%$1.13B$2.02B-17.0033,000High Trading VolumeVRDNViridian Therapeutics2.5601 of 5 stars$13.12+5.9%$36.70+179.7%+2.1%$1.07B$302,000.00-3.0450Positive NewsAnalyst ForecastPNTGThe Pennant Group2.8435 of 5 stars$29.55+3.4%$35.60+20.5%+27.3%$1.03B$695.24M43.465,340Positive NewsGap UpCDNACareDx3.6996 of 5 stars$16.36+6.5%$30.33+85.4%+13.5%$855.26M$346.42M-6.06740Gap UpFLGTFulgent Genetics4.0428 of 5 stars$20.12+2.1%$24.00+19.3%-2.4%$612.53M$292.45M-3.641,010EHABEnhabit2.116 of 5 stars$10.44+1.5%$8.50-18.5%+18.1%$528.40M$1.03B-4.5010,900News CoveragePositive NewsGap Up Related Companies and Tools Related Companies Teladoc Health Competitors Grail Competitors AdaptHealth Competitors agilon health Competitors Aveanna Healthcare Competitors Viridian Therapeutics Competitors The Pennant Group Competitors CareDx Competitors Fulgent Genetics Competitors Enhabit Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.